vailsymposium

As stem cells have transitioned from an area of medical research to clinical therapy with multiple applications, questions have arisen such as “where have they been most successful,” “what are the limitations,” “what are the implications for longevity,” and “where does the science go from here?”

Join Dr. Johnny Huard, chief scientific officer and director at the Linda & Mitch Hart Center for Regenerative and Personalized Medicine at the Steadman Philippon Research Institute, and a fellow medical practitioner and stem cell researcher, as Vail Symposium explores the future directions of stem cell research.